Managed Healthcare

Expert panelists will discuss the legal, financial and policy considerations shaping one of healthcare’s most debated programs during a free webinar, The Great #340B Debate. Register now and join us on July 23 👉 hubs.li/Q04pjNS_0 #ManagedCare #DrugPricing

New research from USC found an association between high-pesticide produce and lung cancer in non-smoking women under 50. Researchers stress this is not a reason to stop eating fruits and vegetables, but it is a reminder that lung cancer can affect anyone. managedhealthcareexecutive.com/shorts/is-ther…

Medicare's HIV care population is set to nearly double by 2035, and the price tag will nearly triple: $187.2B over 10 years. The driver? Antiretroviral therapy. @JAMANetworkOpen modeling study breaks it down. #HIV #Medicare #HealthPolicy hubs.li/Q04p4gVX0

University of Vermont dermatologists argue routine liver enzyme and triglyceride testing for isotretinoin patients without risk factors should shift to a symptom-based approach, citing unnecessary patient anxiety and cost, in a new JAMA Dermatology viewpoint.

Vaccine or monoclonal antibody? Marc Elia, Chairman of the Board of Invivyd, explains the key difference and why it matters for COVID-19 prevention. #COVID19 #MonoclonalAntibodies #Vaccines #Biotech

We’re excited to present The Great 340B Debate, where experts will examine competing perspectives & discuss what policy changes could mean for your organization. Register today to join the free webinar on July 23 👉hubs.li/Q04nFJzY0 #ManagedCare #HealthcarePolicy #340B

How do you choose the right testing strategy for #ALK-positive #NSCLC, and what informs first-line treatment decisions today? Experts discuss tissue vs. liquid biopsy, NGS, IHC, FISH and #NCCN-preferred therapies in this video: hubs.li/Q04mlGFH0

Innovation and financial sustainability aren't competing priorities, says David Chen, Pharm.D. of Kaiser Permanente. Clinician-led contracting around preferred therapies builds savings that fund the next wave of innovation.

No USPSTF guidelines exist for MASH screening. Researcher David O. Garcia, Ph.D., says closing that gap requires a multidisciplinary approach and real funding for evidence-based care.

Hispanic and Latino communities face higher rates of MASH, and lifestyle factors only tell part of the story. David O. Garcia, Ph.D., breaks down the genetic component at play: the PNPLA3 risk allele. hubs.li/Q04m_cdY0

Many people attribute liver disease to alcohol, only to discover a genetic condition like MASH is actually responsible. David O. Garcia, Ph.D., shares the "aha" moments that change how patients and families understand their health history. hubs.li/Q04m_wfv0

Study finds associations between particular speech patterns and particular schizophrenia symptoms hubs.li/Q04mKCXD0

Lung cancer is increasingly showing up in young non-smokers, especially women. USC researcher Jorge Nieva, M.D., suspects pesticide residues in fruits, vegetables and whole grains may be part of the reason. hubs.li/Q04myNtv0

Big news in pharmacy benefits: Abarca and LucyRx are merging, creating a combined 9M+ members and $15B in drug spend under one roof. hubs.li/Q04md-6F0

The FDA just approved Skinvive by Juvéderm for horizontal neck lines — the first hyaluronic acid injectable cleared for this area. Already approved for cheeks since 2023, now tackling tech neck too. Broad availability coming later in 2026. hubs.ly/Q04m2cjH0

A look behind the scenes 🎬 If you missed yesterday's live session, the recording is now available! 🔗 Watch the full Economics of CGT webinar here: hubs.li/Q04m1Wbg0 #CellandGeneTherapy #HealthcarePolicy #ValueBasedCare #DrugCostManagement #ManagedCare

Can a patient cook for themselves? Get out of bed? Sleep? Pain scores miss this. Should functional assessment be the new standard? hubs.li/Q04lZkSd0

Last chance to register for today's free webinar‼️ Join our expert panel at 12 pm EDT for a discussion on the economic future of cell and gene therapy. Register now: hubs.li/Q04lQYnM0 #CellTherapy #GeneTherapy #HealthcarePolicy #ManagedCare #ValueBasedCare

700+ rural hospitals risk closing without 340B savings. See how drug pricing margins keep ERs, maternity and behavioral health units open. hubs.li/Q04lMk060